DaVita Inc. stock outperforms competitors despite losses on the day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Kidney care giant DaVita evolves beyond dialysis, stays committed to downtown Denver
As DaVita marks a major milestone, its top executive reveals where the Dever-beased business and its 3,000 downtown employees ...
DaVita price target raised to $165 from $150 at TD Cowen
TD Cowen analyst Gary Taylor raised the firm’s price target on DaVita (DVA) to $165 from $150 and keeps a Hold rating on the shares. The firm ...
Barclays Remains a Hold on DaVita (DVA)
In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on DaVita (DVA – Research Report), with a price target of ...